TNF and Cowden disease: The biological agents used for CD treatment include anti-tumor necrosis factor (TNF)-α agents, anti-interleukin (IL) 12/23 antibodies, and anti-α4β7 integrin antibodies; moreover, anti-IL-23 antibodies were added in 2022.